MicroRNAs as novel immunotherapeutics

A large unmet need exists for cost-effective, widely available antineoplastic immunotherapeutic agents with a robust translational potential. MicroRNAs (miRNAs) that regulate tumor-mediated immunosuppression or immune checkpoints can induce robust therapeutic immune responses, indicating that miRNAs...

Descripción completa

Detalles Bibliográficos
Autores principales: Heimberger, Amy B, Gilbert, Mark, Rao, Ganesh, Wei, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782519/
https://www.ncbi.nlm.nih.gov/pubmed/24083077
http://dx.doi.org/10.4161/onci.25124
_version_ 1782285568455999488
author Heimberger, Amy B
Gilbert, Mark
Rao, Ganesh
Wei, Jun
author_facet Heimberger, Amy B
Gilbert, Mark
Rao, Ganesh
Wei, Jun
author_sort Heimberger, Amy B
collection PubMed
description A large unmet need exists for cost-effective, widely available antineoplastic immunotherapeutic agents with a robust translational potential. MicroRNAs (miRNAs) that regulate tumor-mediated immunosuppression or immune checkpoints can induce robust therapeutic immune responses, indicating that miRNAs may ultimately become part of the portfolio of anticancer immunotherapeutics.
format Online
Article
Text
id pubmed-3782519
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-37825192013-09-30 MicroRNAs as novel immunotherapeutics Heimberger, Amy B Gilbert, Mark Rao, Ganesh Wei, Jun Oncoimmunology Author's View A large unmet need exists for cost-effective, widely available antineoplastic immunotherapeutic agents with a robust translational potential. MicroRNAs (miRNAs) that regulate tumor-mediated immunosuppression or immune checkpoints can induce robust therapeutic immune responses, indicating that miRNAs may ultimately become part of the portfolio of anticancer immunotherapeutics. Landes Bioscience 2013-08-01 2013-05-28 /pmc/articles/PMC3782519/ /pubmed/24083077 http://dx.doi.org/10.4161/onci.25124 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Author's View
Heimberger, Amy B
Gilbert, Mark
Rao, Ganesh
Wei, Jun
MicroRNAs as novel immunotherapeutics
title MicroRNAs as novel immunotherapeutics
title_full MicroRNAs as novel immunotherapeutics
title_fullStr MicroRNAs as novel immunotherapeutics
title_full_unstemmed MicroRNAs as novel immunotherapeutics
title_short MicroRNAs as novel immunotherapeutics
title_sort micrornas as novel immunotherapeutics
topic Author's View
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782519/
https://www.ncbi.nlm.nih.gov/pubmed/24083077
http://dx.doi.org/10.4161/onci.25124
work_keys_str_mv AT heimbergeramyb micrornasasnovelimmunotherapeutics
AT gilbertmark micrornasasnovelimmunotherapeutics
AT raoganesh micrornasasnovelimmunotherapeutics
AT weijun micrornasasnovelimmunotherapeutics

Ejemplares similares